Skip to main content

and
  1. Article

    Oral low dose and topical tamoxifen for breast cancer prevention: modern approaches for an old drug

    Tamoxifen is a drug that has been in worldwide use for the treatment of estrogen receptor (ER)-positive breast cancer for over 30 years; it has been used in both the metastatic and adjuvant settings. Tamoxifen...

    Matteo Lazzeroni, Davide Serrano, Barbara K Dunn in Breast Cancer Research (2012)

  2. No Access

    Article

    Update on Phase I/II Breast Cancer Prevention Trials

    The greatest success in breast cancer prevention has been with two agents, tamoxifen and raloxifene, both of which are approved by the US Food and Drug Administration (FDA) for the risk reduction of invasive b...

    Brandy M. Heckman-Stoddard, Kathleen A. Foster in Current Breast Cancer Reports (2011)